This study was designed to evaluate the changes of HIF-1α, EPO and VEGF in the myocardium of OSAHS animal models we developed previously12 and to further investigate the effects of MAD treatment on these changes, providing evidence to guide clinical treatment. The gene discussed is EPO; the disease is obstructive sleep apnea syndrome.